The Dynaris Apogee is FDA Cleared
Download the Physician’s Letter
If you’re interested in taking a closer look at Dynaris Technology and how we can help improve your practice and patient health, please click below to view and download our Physician’s Letter.
This letter is exclusive to medical care providers.
Oxygen Delivery Means Nothing If It Can’t Reach Its Target
Your patients’ current oxygen delivery methods are outdated, wasteful and ineffective compared to what’s next. These original systems haven’t changed in decades and continue to deliver oxygen equally to each nostril despite studies proving the nasal cycle hinders such treatment. While an equal distribution of airflow makes sense, clinical studies have successfully demonstrated that the patient’s oxygen delivery method must be able to detect obstructions (that naturally occur within the nasal cycle) to improve therapy and avoid waste. Dynaris has the only technology that detects nasal blockages and redirects flow to the most patent naris. Patients can now count on receiving their prescribed dosage without wasting oxygen or needing to increase their oxygen flow rate to compensate. Dynaris Technology is designed for the nasal cycle and other nasal resistance attributes.
Comments From Professionals
“I learned about Dynaris’ nasal cycle research several years ago. I’m glad to hear they now have perfected an oxygen delivery system that senses which nostril you’re breathing out of and only delivers 02 to that nares. This efficient targeted delivery should not only enhance oxygen saturation but will virtually cut oxygen use by half. A brilliant discovery!”
“Oxygen therapy has been a huge part of medical treatment, but little has been done to improve it over the last few decades. The founder, Lon Aylsworth has made it his mission to modernize the understanding and delivery of oxygen. The design improvements are revolutionary and brilliant, but you also wonder why no one ever took this approach before. We are all looking forward to the breakthroughs that will come as a result of this new approach to oxygen therapy.”
“Patients no longer need to suffer nasal irritation for the benefits of life-sustaining oxygen.”